Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
997
Total Claims
$1.4M
Drug Cost
52
Beneficiaries
$28K
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+2272%
Cost per patient vs peers
$28K vs $1,174 avg
+406%
Brand preference vs peers
44.9% vs 8.9% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
Brand vs Generic
Brand: 436 claims · $1.4M
Generic: 535 claims · $55K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Bictegrav/Emtricit/Tenofov Ala | 115 | $490K |
| Dolutegravir Sodium | 52 | $187K |
| Fostemsavir Tromethamine | 17 | $159K |
| Emtricitab/Rilpiviri/Tenof Ala | 37 | $145K |
| Abacavir/Dolutegravir/Lamivudi | 31 | $143K |
| Enfuvirtide | 17 | $67K |
| Dolutegravir/Rilpivirine | 11 | $41K |
| Darunavir/Cobicistat | 17 | $41K |
| Maraviroc | 12 | $18K |
| Efavirenz/Emtricit/Tenofovr Df | 12 | $18K |
| Rivaroxaban | 14 | $8,247 |
| Fluticasone/Vilanterol | 15 | $6,517 |
| Tiotropium Bromide | 12 | $6,303 |
| Budesonide/Formoterol Fumarate | 13 | $5,258 |
| Abacavir Sulfate | 11 | $3,572 |
Prescribing Profile
Patient Profile
61
Avg Age
39%
Female
2.24
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About